# TEN Holdings, Inc.: financial statements, quarterly

XHLD · Nasdaq · CIK 2030954 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/xhld.md) · [Financials](/companies/xhld/financials.md) · [Filings](/companies/xhld/filings.md) · [Insiders](/companies/xhld/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/xhld/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [1,128](/filings/0001641172-25-011581.md) | [1,023](/filings/0001641172-25-023655.md) | [535](/filings/0001493152-25-021532.md) | [818 d](/filings/0001493152-26-011249.md) | [739](/filings/0001493152-26-023745.md) | [1,116](/filings/0001493152-26-036861.md) | [543](/filings/0001493152-25-021532.md) | [706 d](/filings/0001493152-26-011249.md) | [853](/filings/0001493152-26-023745.md) | [731](/filings/0001493152-26-036861.md) |
| Cost of revenue | $k | [283](/filings/0001641172-25-011581.md) | [141](/filings/0001641172-25-023655.md) | [109](/filings/0001493152-25-021532.md) | [118 d](/filings/0001493152-26-011249.md) | [186](/filings/0001493152-26-023745.md) | [175](/filings/0001493152-26-036861.md) | [138](/filings/0001493152-25-021532.md) | [164 d](/filings/0001493152-26-011249.md) | [307](/filings/0001493152-26-023745.md) | [104](/filings/0001493152-26-036861.md) |
| Gross profit | $k | [845](/filings/0001641172-25-011581.md) | [882](/filings/0001641172-25-023655.md) | [426](/filings/0001493152-25-021532.md) | [700 d](/filings/0001493152-26-011249.md) | [553](/filings/0001493152-26-023745.md) | [941](/filings/0001493152-26-036861.md) | [405](/filings/0001493152-25-021532.md) | [542 d](/filings/0001493152-26-011249.md) | [546](/filings/0001493152-26-023745.md) | [627](/filings/0001493152-26-036861.md) |
| Selling, general and administrative | $k | not reported | not reported | not reported | not reported | not reported | [2,153](/filings/0001493152-26-036861.md) | not reported | not reported | not reported | [3,609](/filings/0001493152-26-036861.md) |
| Operating income | $k | [(374)](/filings/0001641172-25-011581.md) | [(374)](/filings/0001641172-25-023655.md) | [(899)](/filings/0001493152-25-021532.md) | [(1,080) d](/filings/0001493152-26-011249.md) | [(4,762)](/filings/0001493152-26-023745.md) | [(1,360)](/filings/0001493152-26-036861.md) | [(1,927)](/filings/0001493152-25-021532.md) | [(5,378) d](/filings/0001493152-26-011249.md) | [(2,843)](/filings/0001493152-26-023745.md) | [(2,993)](/filings/0001493152-26-036861.md) |
| Interest expense | $k | [26.0](/filings/0001641172-25-011581.md) | [48.0](/filings/0001641172-25-023655.md) | [62.0](/filings/0001493152-25-021532.md) | [82.0 d](/filings/0001493152-26-011249.md) | [69.0](/filings/0001493152-26-023745.md) | [80.0](/filings/0001493152-26-036861.md) | [59.0](/filings/0001493152-25-021532.md) | [34.0 d](/filings/0001493152-26-011249.md) | [61.0](/filings/0001493152-26-023745.md) | [28.0](/filings/0001493152-26-036861.md) |
| Income tax | $k | not reported | not reported | [(9.0)](/filings/0001493152-25-021532.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $k | [(405)](/filings/0001641172-25-011581.md) | [(420)](/filings/0001641172-25-023655.md) | [(975)](/filings/0001493152-25-021532.md) | [(1,167) d](/filings/0001493152-26-011249.md) | [(4,836)](/filings/0001493152-26-023745.md) | [(2,784)](/filings/0001493152-26-036861.md) | [(1,987)](/filings/0001493152-25-021532.md) | [(9,902) d](/filings/0001493152-26-011249.md) | [(2,903)](/filings/0001493152-26-023745.md) | [(2,985)](/filings/0001493152-26-036861.md) |
| Diluted EPS | $ per share | [(0.02)](/filings/0001641172-25-011581.md) | [(0.02)](/filings/0001641172-25-023655.md) | [(0.04)](/filings/0001493152-25-021532.md) | not reported | [(2.68)](/filings/0001493152-26-023745.md) | [(1.95)](/filings/0001493152-26-036861.md) | [(0.10)](/filings/0001493152-25-021532.md) | not reported | [(0.73)](/filings/0001493152-26-023745.md) | [(0.70)](/filings/0001493152-26-036861.md) |
| Basic EPS | $ per share | [(0.02)](/filings/0001641172-25-011581.md) | [(0.02)](/filings/0001641172-25-023655.md) | [(0.04)](/filings/0001493152-25-021532.md) | not reported | [(2.68)](/filings/0001493152-26-023745.md) | [(1.95)](/filings/0001493152-26-036861.md) | [(0.10)](/filings/0001493152-25-021532.md) | not reported | [(0.73)](/filings/0001493152-26-023745.md) | [(0.70)](/filings/0001493152-26-036861.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2022-12-31) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [0.4](/filings/0001641172-25-001303.md) | not reported | not reported | not reported | [0.0](/filings/0001493152-26-011249.md) | [0.2](/filings/0001641172-25-011581.md) | [0.7](/filings/0001493152-26-036861.md) | [0.3](/filings/0001493152-25-021532.md) | [1.6](/filings/0001493152-26-036861.md) | [0.1](/filings/0001493152-26-023745.md) | [5.8](/filings/0001493152-26-036861.md) |
| Current assets | $m | not reported | [0.9](/filings/0001641172-25-001303.md) | not reported | not reported | not reported | [1.8](/filings/0001493152-26-011249.md) | [2.9](/filings/0001641172-25-011581.md) | [3.3](/filings/0001641172-25-023655.md) | [3.2](/filings/0001493152-25-021532.md) | [10.4](/filings/0001493152-26-036861.md) | [7.4](/filings/0001493152-26-023745.md) | [9.2](/filings/0001493152-26-036861.md) |
| Total assets | $m | not reported | [4.8](/filings/0001641172-25-001303.md) | not reported | not reported | not reported | [6.4](/filings/0001493152-26-011249.md) | [10.8](/filings/0001641172-25-011581.md) | [11.1](/filings/0001641172-25-023655.md) | [10.7](/filings/0001493152-25-021532.md) | [12.0](/filings/0001493152-26-036861.md) | [8.0](/filings/0001493152-26-023745.md) | [9.5](/filings/0001493152-26-036861.md) |
| Current liabilities | $m | not reported | [3.1](/filings/0001641172-25-001303.md) | not reported | not reported | not reported | [7.5](/filings/0001493152-26-011249.md) | [5.4](/filings/0001641172-25-011581.md) | [5.3](/filings/0001641172-25-023655.md) | [6.5](/filings/0001493152-25-021532.md) | [7.3](/filings/0001493152-26-036861.md) | [5.9](/filings/0001493152-26-023745.md) | [3.1](/filings/0001493152-26-036861.md) |
| Total liabilities | $m | not reported | [3.7](/filings/0001641172-25-001303.md) | not reported | not reported | not reported | [8.0](/filings/0001493152-26-011249.md) | [5.9](/filings/0001641172-25-011581.md) | [5.7](/filings/0001641172-25-023655.md) | [7.0](/filings/0001493152-25-021532.md) | [7.7](/filings/0001493152-26-036861.md) | [6.3](/filings/0001493152-26-023745.md) | [3.1](/filings/0001493152-26-036861.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | [5.6](/filings/0001493152-25-021532.md) | [4.0](/filings/0001641172-25-011581.md) | [3.7](/filings/0001641172-25-023655.md) | [4.6](/filings/0001493152-25-021532.md) | not reported | not reported | not reported |
| Shareholders' equity | $m | [2.7](/filings/0001641172-25-001303.md) | [1.1](/filings/0001493152-26-011249.md) | [0.6](/filings/0001641172-25-023655.md) | [0.2](/filings/0001493152-25-021532.md) | [(0.7)](/filings/0001493152-25-021532.md) | [(1.6)](/filings/0001493152-26-036861.md) | [4.9](/filings/0001493152-26-036861.md) | [5.3](/filings/0001493152-26-036861.md) | [3.8](/filings/0001493152-25-021532.md) | [4.3](/filings/0001493152-26-036861.md) | [1.7](/filings/0001493152-26-036861.md) | [6.4](/filings/0001493152-26-036861.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(581)](/filings/0001641172-25-011581.md) | [(426) d](/filings/0001641172-25-023655.md) | [(756) d](/filings/0001493152-25-021532.md) | [(722) d](/filings/0001493152-26-011249.md) | [(6,785)](/filings/0001493152-26-023745.md) | [(792) d](/filings/0001493152-26-036861.md) | [(1,458) d](/filings/0001493152-25-021532.md) | [(1,030) d](/filings/0001493152-26-011249.md) | [(1,102)](/filings/0001493152-26-023745.md) | [(1,594) d](/filings/0001493152-26-036861.md) |
| Capital expenditure | $k | [11.0](/filings/0001641172-25-011581.md) | [19.0 d](/filings/0001641172-25-023655.md) | [6.0 d](/filings/0001493152-25-021532.md) | [2.0 d](/filings/0001493152-26-011249.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [25.0](/filings/0001641172-25-011581.md) | [25.0](/filings/0001641172-25-023655.md) | [25.0](/filings/0001493152-25-021532.md) | [1.8](/filings/0001493152-26-023745.md) | [1.4](/filings/0001493152-26-036861.md) | [20.6](/filings/0001493152-25-021532.md) | [4.0](/filings/0001493152-26-023745.md) | [4.3](/filings/0001493152-26-036861.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 11,977,443 at 2026-08-05, from the cover of the [10-Q filed 2026-08-10](/filings/0001493152-26-036861.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.